- Home
- TWO vs NRIX Comparison
TWO vs NRIX Comparison
Compare TWO & NRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TWO
- NRIX
- Stock Information
- Founded
- TWO 2009
- NRIX 2009
- Country
- TWO United States
- NRIX United States
- Employees
- TWO N/A
- NRIX N/A
- Industry
- TWO Real Estate Investment Trusts
- NRIX Biotechnology: Pharmaceutical Preparations
- Sector
- TWO Real Estate
- NRIX Health Care
- Exchange
- TWO Nasdaq
- NRIX Nasdaq
- Market Cap
- TWO 1.1B
- NRIX 908.0M
- IPO Year
- TWO 2009
- NRIX 2020
- Fundamental
- Price
- TWO $10.59
- NRIX $12.73
- Analyst Decision
- TWO Buy
- NRIX Strong Buy
- Analyst Count
- TWO 8
- NRIX 16
- Target Price
- TWO $13.21
- NRIX $30.44
- AVG Volume (30 Days)
- TWO 1.9M
- NRIX 747.9K
- Earning Date
- TWO 07-29-2025
- NRIX 07-10-2025
- Dividend Yield
- TWO 17.05%
- NRIX N/A
- EPS Growth
- TWO N/A
- NRIX N/A
- EPS
- TWO N/A
- NRIX N/A
- Revenue
- TWO $370,696,000.00
- NRIX $56,417,000.00
- Revenue This Year
- TWO N/A
- NRIX $16.69
- Revenue Next Year
- TWO N/A
- NRIX N/A
- P/E Ratio
- TWO N/A
- NRIX N/A
- Revenue Growth
- TWO N/A
- NRIX N/A
- 52 Week Low
- TWO $10.16
- NRIX $8.18
- 52 Week High
- TWO $14.28
- NRIX $29.56
- Technical
- Relative Strength Index (RSI)
- TWO 43.85
- NRIX 62.83
- Support Level
- TWO $10.18
- NRIX $11.34
- Resistance Level
- TWO $11.05
- NRIX $12.90
- Average True Range (ATR)
- TWO 0.25
- NRIX 0.66
- MACD
- TWO 0.06
- NRIX 0.02
- Stochastic Oscillator
- TWO 44.83
- NRIX 90.17
About TWO Two Harbors Investment Corp
Two Harbors Investment Corp is a real estate investment trust focused on investing in, financing, and managing residential mortgage-backed securities, or RMBS; residential mortgage loans; mortgage servicing rights; and commercial real estate. The majority of the company's investment portfolio is split between agency RMBS purchased from government-sponsored enterprises and nonagency RMBS. Two Harbors derives nearly all of its revenue in the form of interest income collected from its investments. The majority of this income is generated by available-for-sale securities, while residential mortgage loans held for investment in securitization trusts also contribute a sizable amount.
About NRIX Nurix Therapeutics Inc. Common stock
Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company's pipeline comprises targeted protein degraders of Brutons tyrosine kinase, or BTK, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, or CBL-B, an E3 ligase that regulates T cell activation. Its drug candidate from protein degradation portfolio, NX-2127, is an orally available BTK degrader for the treatment of relapsed or refractory B-cell malignancies.